Binding Site Competitors and Similar CompaniesClear all

EKF Diagnostics's competitors and similar companies include SpeeDx, QIAGEN and Transine Therapeutics.

	EKF Diagnostics EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.	SpeeDx SpeeDx is a provider of multiplex quantitative polymerase chain reaction (qPCR) and isothermal amplification solutions for clinical diagnostics.	QIAGEN QIAGEN is a company that provides sample technology solutions.	Transine Therapeutics Transine Therapeutics is a developer of biotech platform tat specializes in development of therapeutic RNAs.
Founding Date	Founding Date 1990	Founding Date 2009	Founding Date 1984	Founding Date 2020
Type	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech chemicals clinical research distribution medical devices medical diagnostics	Tags Technology biotech clinical research genetics medical diagnostics	Tags Healthcare clinical research medical devices	Tags Technology biotech clinical research medical diagnostics
Locations	Locations Penarth, GB HQ Shanghai, CN Barleben, DE Leipzig, DE Boerne, US Elkhart, US	Locations Eveleigh, AU HQ London, GB Austin, US	Locations Venlo, NL HQ Clayton, AU São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN Shanghai, CN see more	Locations Babraham, GB HQ
Employees	Employees 303	Employees 842% decrease	Employees 5,6541% decrease	Employees 517% decrease
Valuation ($)	Valuation ($) 157.5 m	Valuation ($) N/A	Valuation ($) 9.3 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) £51.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $2.1b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods £19.7m (FY, 2025)	Cost of goods N/A	Cost of goods $577.3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit £32.1m (FY, 2025)	Gross profit N/A	Gross profit $1.5b (FY, 2025)	Gross profit N/A
Net income	Net income £2.5m (FY, 2025)	Net income N/A	Net income $437m (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 15m (over 6 years ago)	Latest funding round N/A	Latest funding round $ 12.6m (about 5 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 30m	Total funding raised $ 4m	Total funding raised $ 12.6m